The inhibition activity on the dihydrofolate reductase (DHFR) has been measured in BC cells treated with gold complexes 5 and 6 within either 4 or 12 h upon treatment and in not treated cells, at the same conditions, as control. The gene discussed is DHFR; the disease is breast cancer.